학술논문

Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma
Document Type
Article
Source
In: Human Vaccines and Immunotherapeutics. (Human Vaccines and Immunotherapeutics, 2022, 18(3))
Subject
Language
English
ISSN
2164554X
21645515